Mesenchymal stem cells and bone regeneration;Cellule staminali mesenchimali e medicina rigenerativa dell'osso

Recenti Progressi in Medicina

Volumn 99, Issue 2, 2008, Pages 75-82

  Ciavarella, Sabino ^a   De Matteo, Monica ^a   Cafforio, Paola ^a   Dammacco, Franco ^a   Silvestris, Franco ^a  

^a POLICLINICO   (Italy)

Author keywords

Bone disease; Cell therapy; Mesenchymal stem cells; Regenerative medicine

Indexed keywords

BONE DISEASE; BONE REGENERATION; CELL DIFFERENTIATION; CELL POPULATION; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR DYNAMICS; REGENERATIVE MEDICINE; REVIEW;

BONE REGENERATION; HUMANS; MESENCHYMAL STEM CELLS;

EID: 41549128508     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation and application in cell and gene therapy. J Cell Mol Med 2004; 8: 301-16.
2. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Stem Cells 2006; 24: 1294-301.
3. Williams JT, Southerland SS, Souza J, Calcutt AF, Cartledge RG. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 1999; 65: 22-6.
4. Mauney JR, Volloch V, Kaplan DL. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 2005; 11: 787-802.
5. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue and umbilical cord blood. Exp Hematol 2005; 33: 1402-16.
6. Chang YJ, Shih DT, Tseng CP, Hsieh TB, Lee DC, Hwang SM, et al. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 2006; 24: 679-85.
7. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnol 2007; 25: 100-6.
8. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25: 1384-92.
9. Friedenstein AJ, Gorskaja U, Kulagina NN. Fibroblast precursor in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267-74.
10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
11. Hung SC, Chen NJ, Hsieh SL, Li H, Ma HL, Lo WH. Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells 2002; 20: 249-58.
12. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-8.
13. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, et al. Cotransplantation of HLA-identical sibling culture expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389-98.
14. Karahuseiynoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007; 25: 319-31.
15. Kadivar M, Khatami S, Mortazavi Y, Shokrgozar MA, Taghikhani M, Soleimani M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun 2006; 340: 639-47.
16. Phillips JE, Gersbach CA, Garcìa AJ. Virus-based gene therapy for bone regeneration. Biomaterials 2007; 28: 21-29.
17. Sinn PL, Sauter SL, McCray Jr PB. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors; design, biosafety, and production. Gene Therapy 2005; 12: 1089-98.
18. Sugiyama O, An DS, Kung SP, Feeley BT, Gamradt S, Liu NQ, et al. Lentivirus-mediated gene trasfer induces long-term trasgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther 2005; 11: 390-98.
19. Hsu WK, Sugiyama O, Park SH, Conduah A, Feeley BT, Liu NQ, et al. Lentiviral-mediated gene trasfer enhances healing of segmental femoral defects in rats. Bone 2007; 40: 931-38.
20. Musgrave DS, Bosch P, Ghivizzani S, Robbins PD, Evans CH, Huard J. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 1999; 24: 541-7.
21. Sylvestris F, Cafforio P, Calvani N, Dammacco F. Impaired osteoblastogenesis in myeloma bone disease: role of upregulated apoptosis by cytokines and malignant plasma cells. Br J Haematol 2004; 126: 475-86.
22. Silvestris F, Lombardi L, De Matteo M, Bruno A, Dammacco F. Myeloma bone disease: pathogenetic mechanisms and clinical assessment. Leuk Res 2007; 31: 129-38.